Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

HHS Stock - Harte Hanks Stock Trading


home / stock / hhs

HHS HHS Quote HHS Short HHS News HHS Articles HHS Message Board

MWN AI Summary *

Harte-Hanks, Inc. (NASDAQ: HHS) is a marketing services company that specializes in data-driven marketing solutions. Founded in 1923 and headquartered in San Antonio, Texas, the company has established itself as a leader in the integration of database marketing, customer engagement, and multichannel communication strategies. As a data-centric firm, Harte-Hanks offers a range of services, including direct mail, digital marketing, and analytics, which help businesses effectively reach their target audiences and optimize marketing performance.

The company primarily serves various industries, including retail, telecommunications, and financial services, leveraging its extensive databases to enhance customer relationship management and drive sales growth for its clients. Harte-Hanks employs advanced technology and data analytics tools to provide insights that empower businesses to make informed decisions and tailor their marketing campaigns.

Harte-Hanks has undergone significant restructuring in recent years, focusing on improving operational efficiency and scaling its digital offerings. This shift reflects the broader trend in the marketing industry towards a greater integration of digital channels and a reliance on data analytics. The company's ability to adapt to these changes has positioned it competitively in a rapidly evolving landscape.

Despite facing challenges, including fluctuations in market demand and competition from other marketing firms, Harte-Hanks remains committed to delivering high-quality services and building long-term partnerships with its clients. As of October 2023, investors are keenly watching the company's strategic moves, particularly in expanding its digital capabilities and enhancing customer engagement. With a strong emphasis on innovation and customer service, Harte-Hanks aims to capitalize on emerging opportunities in the marketing sector, reinforcing its status as a vital player in the industry.

MWN AI Analysis *

As of October 2023, Harte-Hanks, Inc. (NASDAQ: HHS) presents an intriguing investment opportunity amid evolving market conditions. Historically known for its marketing services, the company has recently pivoted towards enhancing its digital and data-driven offerings, which are crucial for staying competitive in a landscape increasingly dominated by technology and analytics.

One of the most significant factors to consider is the ongoing digital transformation across all industries. Harte-Hanks has made strategic investments in its digital capabilities, enabling it to provide targeted marketing solutions and enhance customer engagement for businesses. This positions HHS favorably in a market where organizations increasingly seek to optimize their marketing expenditures towards measurable outcomes. Therefore, investors should pay close attention to the firm’s product development and partnerships in the tech space that could enhance its operational efficiencies and client offerings.

Financially, recent quarterly reports have suggested a moderate improvement in revenue streams, attributed to enhanced service diversification and cost-cutting measures in operations. However, it's essential to remain cautious about the company’s debt levels and profitability margins, which have been under pressure in prior periods.

Furthermore, the competitive landscape for marketing services continues to intensify, with larger firms leveraging economies of scale. Harte-Hanks must continue to innovate and differentiate its offerings to capture market share and sustain growth.

From a valuation standpoint, HHS appears reasonably priced relative to its peers, especially considering its growth potential in the digital marketing space. Investors should monitor performance metrics and expect volatility as the company adapts to the fast-changing environment.

In conclusion, while Harte-Hanks may not be without its risks, its strategic pivots towards digital marketing and customer engagement present a compelling case for long-term investors looking to tap into the evolving marketing landscape. Due diligence and awareness of market trends will be critical in making informed investment decisions.

* MWN AI Summary and Analysis is based on asking OpenAI to summarize and analyze the company and stock symbol.


About | Harte-Hanks, Inc. (NASDAQ:HHS)

Harte-Hanks Inc is a marketing services company that provides multichannel marketing solutions as well as consulting, data analytics, and strategic assessment. The company's offerings focus on business-to-business, retail, finance, and automotive segments through digital, social, mobile, and print media offerings. Harte-Hanks strives to develop better customer relationships through its marketing and analytical services for clients. The majority of its revenue is derived from its marketing services in the retail, technology, and consumer brand segments.

Quote | Harte-Hanks, Inc. (NASDAQ:HHS)

Last:$3.37
Change Percent: -0.3%
Open:$3.37
Close:$3.38
High:$3.37
Low:$3.37
Volume:911
Last Trade Date Time:07/16/2025 11:19:25 am

News | Harte-Hanks, Inc. (NASDAQ:HHS)

  • Emergent BioSolutions signs contract modification award for CNJ-016

    2025-07-08 17:25:19 ET More on Emergent Biosolutions Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful Emergent BioSolutions Inc. 2025 Q1 - Results - Earnings Call Presentation Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Tra...

    • July 08, 2025 05:25:19 pm

    • |
    • SeekingAlpha
    • |
      • HHS Stock
      • HHS Quote
      • HHS Short
      • HHS News
      • HHS Articles
      • HHS Message Board
  • When the Price of (HHS) Talks, People Listen

    2025-07-05 19:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

    • July 05, 2025 07:56:00 pm

    • |
    • Stock Traders Daily
    • |
      • HHS Stock
      • HHS Quote
      • HHS Short
      • HHS News
      • HHS Articles
      • HHS Message Board

Message Board Posts | Harte-Hanks, Inc. (NASDAQ:HHS)

Subject By Source When
$HHS what do you make of this data? Renee investorshub 06/15/2023 5:22:03 AM
$HHS best news of the day jb55 investorshub 06/12/2023 6:04:27 AM
MomentumIts gaining last trade up herbied47 investorshub 06/10/2023 9:58:42 AM
where is the squeeze? investora2z investorshub 06/09/2023 10:05:35 PM
Price gaining last trade up herbied47 investorshub 06/03/2023 3:25:30 AM

MWN AI FAQ **

What are the latest financial performance metrics for Harte-Hanks, Inc. HHS that investors should consider when evaluating its growth potential?

Investors should consider Harte-Hanks, Inc.'s latest financial metrics, including revenue growth, profit margins, EBITDA, and cash flow trends, as well as recent changes in debt levels and customer acquisition costs, to evaluate the company's growth potential.

How has Harte-Hanks, Inc. HHS adapted its marketing strategies to align with current industry trends and consumer behavior shifts?

Harte-Hanks, Inc. has adapted its marketing strategies by integrating data-driven insights, leveraging digital channels, and focusing on personalized customer engagement to align with evolving industry trends and shifts in consumer behavior.

What are the potential risks and opportunities for Harte-Hanks, Inc. HHS in the competitive landscape of marketing services in 2024?

In 2024, Harte-Hanks, Inc. faces risks from increasing competition and rapid technological changes but also has opportunities to leverage data analytics and personalized marketing strategies to enhance customer engagement and differentiate its services in the evolving landscape.

How does Harte-Hanks, Inc. HHS plan to leverage technology to enhance its service offerings and improve client engagement in the coming years?

Harte-Hanks, Inc. plans to leverage advanced data analytics, AI-driven insights, and innovative digital marketing technologies to enhance service offerings and elevate client engagement, aiming to deliver more personalized and efficient solutions in the coming years.

** MWN AI Questions are based on asking OpenAI to ask and answer four questions about the company and stock symbol.

Stock Information

Get HHS Alerts

News, Short Squeeze, Breakout and More Instantly...

Harte-Hanks, Inc. Company Name:

HHS Stock Symbol:

NASDAQ Market:

-0.3% G/L:

$3.37 Last:

911 Volume:

$3.37 Open:

$3.38 Close:

Harte-Hanks, Inc. Website:

Harte-Hanks, Inc. Logo

Ad

Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients
RECENT HHS NEWS
  • HHS - When the Price of (HHS) Talks, People Listen

    2025-07-05 19:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

  • HHS - Harte Hanks, Inc. Appoints David Fisher as President to Lead Next Phase of Client Innovation and Growth

    Proven transformation leader and former CTO David Fisher to spearhead Harte Hanks' next chapter of innovation, efficiency, and client-centric growth CHELMSFORD, MA / ACCESS Newswire / June 30, 2025 / Harte Hanks, Inc. (NASDAQ:HHS), a leading global customer experience company, today annou...

  • HHS - Trading (HHS) With Integrated Risk Controls

    2025-06-14 21:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Important Investor News Alert (NASDAQ: CVKD)

 Logo

  • CVKD - Cadrenal Therapeutics Highlights New Research on Anticoagulation Burden for LVAD Patients

    LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Connect with Us

Join our Telegram Alerts Channel

Telegram

Join our Discord

Discord

Get HHS Alerts

Get HHS Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1